GAMBLE JONES INVESTMENT COUNSEL - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
GAMBLE JONES INVESTMENT COUNSEL ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2022$39,595
-62.3%
61,0000.0%0.00%
-66.7%
Q3 2022$105,000
+38.2%
61,0000.0%0.01%
+50.0%
Q2 2022$76,000
+90.0%
61,0000.0%0.01%
+200.0%
Q1 2022$40,000
-39.4%
61,0000.0%0.00%
-50.0%
Q4 2021$66,000
+17.9%
61,000
+96.8%
0.00%0.0%
Q3 2021$56,000
-31.7%
31,0000.0%0.00%
-20.0%
Q2 2021$82,000
-26.8%
31,0000.0%0.01%
-37.5%
Q1 2021$112,000
+43.6%
31,0000.0%0.01%
+60.0%
Q4 2020$78,0000.0%31,0000.0%0.01%
-16.7%
Q3 2020$78,000
-23.5%
31,0000.0%0.01%
-25.0%
Q2 2020$102,000
+37.8%
31,000
+3.3%
0.01%
+14.3%
Q1 2020$74,000
-43.9%
30,000
+7.1%
0.01%
-30.0%
Q4 2019$132,000
+10.0%
28,0000.0%0.01%0.0%
Q3 2019$120,000
-26.4%
28,0000.0%0.01%
-28.6%
Q2 2019$163,000
+40.5%
28,000
-6.7%
0.01%
+40.0%
Q1 2019$116,000
+107.1%
30,0000.0%0.01%
+66.7%
Q4 2018$56,00030,0000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders